Phase I Trial of Cisplatin and Pemetrexed in Combination With Panobinostat in Advanced Solid Tumors, With Emphasis on Non-Small Cell Lung Cancer

Trial Profile

Phase I Trial of Cisplatin and Pemetrexed in Combination With Panobinostat in Advanced Solid Tumors, With Emphasis on Non-Small Cell Lung Cancer

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 15 Feb 2017

At a glance

  • Drugs Panobinostat (Primary) ; Cisplatin; Pemetrexed
  • Indications Non-small cell lung cancer; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 19 Jan 2017 Planned primary completion date changed from 1 Dec 2014 to 1 Jun 2017.
    • 31 Aug 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top